Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy
Not Applicable
Completed
- Conditions
- Thyroid Cancer
- Interventions
- Drug: Systemic intravenous lidocaine infusionDrug: normal saline infusion
- Registration Number
- NCT01907997
- Lead Sponsor
- Yonsei University
- Brief Summary
Systemic lidocaine infusion may improve the patients' recovery quality and chronic post surgical pain after robot-assisted thyroidectomy
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
- Age between 20-65
- ASA class I and II
- Thyroid cancer patients who are scheduled for elective robot-assisted thyroidectomy
Read More
Exclusion Criteria
- Allergy to local anesthetics or contraindication to use of lidocaine
- Pregnancy
- Severe cardiovascular disease
- Renal failure
- Liver failure
- Neurologic and psychologic disease
- Chronic treatment with analgesics
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group L Systemic intravenous lidocaine infusion Intravenous lidocaine infusion group Group C normal saline infusion Intravenous normal saline infusion - control group
- Primary Outcome Measures
Name Time Method Quality of recovery 40(QoR-40) score 24hours after operation day Assessing change of the Quality of recovery 40(QoR-40) score between 24hours before and after operation
- Secondary Outcome Measures
Name Time Method Assessing the presence of chronic postsurgical pain(CPSP) 24hours after operation day aspect and site of CPSP 24hours after operation day
Trial Locations
- Locations (1)
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei universiy college of medicine
🇰🇷Seoul, Korea, Republic of